• OPEN AN ACCOUNT
Indian Indices
Nifty
23,501.10 -65.90
(-0.28%)
Sensex
77,209.90 -269.03
( -0.35%)
Bank Nifty
51,661.45 -121.80
( -0.24%)
Nifty IT
35,200.30 263.85
( 0.76%)
Global Indices
Nasdaq
17,689.36 -32.23
(-0.18%)
Dow Jones
39,150.33 15.57
(0.04%)
Hang Seng
18,028.52 -306.80
(-1.67%)
Nikkei 225
38,596.47 -36.55
(-0.09%)
Forex
USD-INR
83.57 0.16
(0.19%)
EUR-INR
89.61 0.01
(0.01%)
GBP-INR
106.03 -0.06
(-0.05%)
JPY-INR
0.53 0.00
(-0.19%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
271.0885563
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
37.06
29508.17
EPS(TTM)
Face Value()
Div & Yield %
63.23
2
2.18
 

Urja Global consolidated net profit rises 411.11% in the March 2024 quarter
May 23,2024
Net profit of Urja Global rose 411.11% to Rs 0.46 crore in the quarter ended March 2024 as against Rs 0.09 crore during the previous quarter ended March 2023. Sales rose 22.37% to Rs 13.02 crore in the quarter ended March 2024 as against Rs 10.64 crore during the previous quarter ended March 2023.

For the full year,net profit rose 33.33% to Rs 2.04 crore in the year ended March 2024 as against Rs 1.53 crore during the previous year ended March 2023. Sales rose 12.35% to Rs 44.47 crore in the year ended March 2024 as against Rs 39.58 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear Ended
 Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.
Sales13.0210.64 22 44.4739.58 12
OPM %1.690.85 -5.193.46 -
PBDT0.490.38 29 3.142.29 37
PBT0.470.09 422 2.851.98 44
NP0.460.09 411 2.041.53 33